{
    "2021-02-12": [
        [
            {
                "time": "2023-02-15",
                "original_text": "Eli Lilly Keeps Piling Up Share Price Gains",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Share Price Gains"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-02-15",
                "original_text": "Eli Lilly Executives Enthusiastic About Alzheimer’s Drug, Analyst Says",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Alzheimer’s Drug",
                        "Enthusiastic"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-02-15",
                "original_text": "Can Coronavirus Antibodies Overcome Their Obstacles?",
                "features": {
                    "keywords": [
                        "Coronavirus Antibodies",
                        "Obstacles"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-02-15",
                "original_text": "Pharma Stock Roundup: AZN's Q4 Earnings, FDA Approval for LLY & SNY's Drugs",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "AZN",
                        "Q4 Earnings",
                        "FDA Approval",
                        "LLY",
                        "SNY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}